Brain metastases (BrM) originating from lung and breast cancer can recruit and activate neutrophils to acquire a tumor-promoting phenotype. It is currently unclear if this phenomenon also occurs in BrM arising from other primary sites. Here, we investigated the effect of tumor cells isolated from melanoma, lung and gastrointestinal (GI) cancer BrM on neutrophil biology and functions. We found that lung and GI, but not melanoma BrM cells produced CXCL8/IL-8, and promoted neutrophil recruitment. Similarly, lung and GI, but not melanoma BrM cells, prolonged the survival of neutrophils, and stimulated them to release MMP9 and CCL4/MIP1β. In situ, lung and GI BrM tissues contained significantly higher numbers of tumor-infiltrating neutrophils compared to melanoma BrM. The levels of neutrophil infiltration significantly correlated with the proliferation index of these tumors. Our findings identify variabilities in the immune microenvironment of BrM with different primary sites, which may ultimately affect their pathophysiology and progression.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jleuko/qiae248DOI Listing

Publication Analysis

Top Keywords

primary sites
12
melanoma brm
12
brain metastases
8
brm
8
lung melanoma
8
brm cells
8
lung
5
tumor-neutrophil interactions
4
interactions microenvironment
4
microenvironment brain
4

Similar Publications

Drug Development.

Alzheimers Dement

December 2024

Burke Neurological Institute, Weill Cornell Medicine, White Plains, NY, USA.

Background: Benfotiamine, a prodrug of thiamine, raises blood levels by 50-100 times to achieve pharmacologic effects. It provides a novel therapeutic direction addressing a well-characterized brain tissue thiamine deficiency and related changes in glucose metabolism in AD. BenfoTeam is a seamless phase 2A-2B "proof of concept" (POC), double-blind, placebo-controlled RCT investigating tolerability, safety, and efficacy of benfotiamine, as a first-in-class small molecule treatment for early AD.

View Article and Find Full Text PDF

Dementia Care Practice.

Alzheimers Dement

December 2024

MINT Memory Clinic, Kitchener, ON, Canada.

Background: Multispecialty Interprofessional Team (MINT) Memory Clinics build capacity for dementia care within primary care. This presentation will provide an overview of the MINT care model and results of a process evaluation of the implementation of the model in three provinces in Canada using the Research Medical Council framework for evaluating complex interventions.

Methods: 178 healthcare providers (HCP) were trained to establish 10 MINT clinics across three Canadian provinces.

View Article and Find Full Text PDF

Background: In Japan, the number of patients with dementia is increasing and there is a shortage of human resources who can conduct detailed psychological examinations, and the development and implementation of new tools is essential for improving dementia care. Japan is one of seven sites across the globe focusing on healthcare system preparedness as part of the Davos Alzheimer's Collaborative Early Detection flagship program. As part of this program, Japan implemented new tools including a digital cognitive assessment (DCA) and blood-based biomarker (BBM) to increase rates of early detection of cognitive impairment.

View Article and Find Full Text PDF

Dementia Care Practice.

Alzheimers Dement

December 2024

Davos Alzheimer's Collaborative, Wayne, PA, USA.

Background: Cognitive impairment is frequently undetected or undiagnosed in the early stages. To increase the rates of detecting cognitive impairment, the Early Detection program of the Davos Alzheimer's Collaborative System Preparedness (DAC-SP) implemented digital cognitive assessments (DCA) in primary care and other non-specialty settings.

Methods: The DAC-SP Early Detection program was initiated in 2021 in seven healthcare systems across six countries.

View Article and Find Full Text PDF

Background: Early symptoms of cognitive impairment are frequently undetected. The Davos Alzheimer's Collaborative System Preparedness (DAC-SP) Early Detection program implemented a digital cognitive assessment (DCA) in primary care and other non-specialty settings to increase the rate of detection of cognitive impairment.

Methods: The DAC-SP Early Detection program was initiated in 2021 in seven healthcare systems across six countries.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!